1. The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
   Yue Pan et al, 2021, Frontiers in Oncology CrossRef
2. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p
   Xiaobo Yu et al, 2020, International Journal of Immunopathology and Pharmacology CrossRef
3. Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer
   Tiia J Honkanen et al, 2023, Cancer Biology & Therapy CrossRef
4. Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
   Wen-juan Liu et al, 2020, Pharmacology & Therapeutics CrossRef
5. HNMT Upregulation Induces Cancer Stem Cell Formation and Confers Protection against Oxidative Stress through Interaction with HER2 in Non-Small-Cell Lung Cancer
   Kuang-Tai Kuo et al, 2022, International Journal of Molecular Sciences CrossRef